A detailed history of Emfo, LLC transactions in Organon & Co. stock. As of the latest transaction made, Emfo, LLC holds 32 shares of OGN stock, worth $508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 32 -0.0%
Holding current value
$508
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$23.4 - $34.25 $2,761 - $4,041
-118 Reduced 78.67%
32 $1,000
Q1 2022

May 04, 2022

SELL
$30.45 - $39.36 $1,735 - $2,243
-57 Reduced 27.54%
150 $5,000
Q4 2021

Jan 27, 2022

SELL
$28.67 - $37.13 $1,003 - $1,299
-35 Reduced 14.46%
207 $6,000
Q3 2021

Oct 26, 2021

SELL
$28.63 - $35.64 $61,955 - $77,124
-2,164 Reduced 89.94%
242 $8,000
Q2 2021

Jul 20, 2021

BUY
$28.45 - $38.0 $68,450 - $91,428
2,406 New
2,406 $73,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.04B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Emfo, LLC Portfolio

Follow Emfo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emfo, LLC with notifications on news.